A RCT of a Combination of Analgesics for Pain Management in Children With a Suspected Fracture
Status:
Unknown status
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
MSK-I is the most common cause for ED visits for children with pain, with a child's risk of
sustaining a fracture ranging from 27-42% by the age of 16 years. MSK-I is known to generate
moderate to severe pain in most children and the ED serves as the critical entry point for
these injured children. This study aims to provide rapid and sustained pain management for
children presenting with a MSK-I in the ED. The investigators will compare the efficacy of 2
possible medication combinations (fentanyl intranasal + oral hydromorphone or fentanyl
intranasal + oral ibuprofen) for the rapid, adequate and sustained pain management of
children with suspected fracture.
The investigators believe that the addition of HM to INF will lead to better pain treatment
by providing a consistent and adequate level of analgesia throughout the entire ED visit,
including prior to physician exam and during painful radiologic procedures.